Treatment of primary disease (breast, non-small cell lung and prostate cancers) with irradiation in case of de novo metastatic cancer

The basis of treatment of primary disease in case of metastatic cancer at diagnosis is based on the knowledge of the natural history of the disease, the biology of the primary tumour and its metastases, advances in modern radiotherapy techniques (modulated intensity, stereotactic radiotherapy) in or...

Full description

Saved in:
Bibliographic Details
Published inCancer radiothérapie
Main Authors Latorzeff, I, Bourgier, C, Pinel, B, Hennequin, C, Jimenez, G, Chapet, O, Zasadny, X
Format Journal Article
LanguageFrench
Published France 01.10.2019
Subjects
Poumon
Primary tumour
Tumeur primitive
Radiothérapie
Lung
Metastatic cancer
Clinical trials
Radiotherapy
Sein
Stéréotaxie
Essais cliniques
SBRT
Breast
Cancer métastatique
Prostate
Online AccessGet full text

Cover

More Information
Summary:The basis of treatment of primary disease in case of metastatic cancer at diagnosis is based on the knowledge of the natural history of the disease, the biology of the primary tumour and its metastases, advances in modern radiotherapy techniques (modulated intensity, stereotactic radiotherapy) in order to improve the survival of patients with advanced disease. The clinical concept of oligometastatic disease at diagnosis has repositioned the interest of local treatment for primitive disease because these patients have a slower evolutionary profile than metastatic disease extended from the outset. This article reviews the indication of radiotherapy as a local treatment for primary cancer in a de novo metastatic diagnosed disease in the case of breast cancer, non-small cell lung cancer and prostate cancer.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1769-6658
DOI:10.1016/j.canrad.2019.08.004